These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32410501)

  • 41. Synthesis and biological evaluation of marine alkaloid-oriented β-carboline analogues.
    Xu T; Shi L; Zhang Y; Wang K; Yang Z; Ke S
    Eur J Med Chem; 2019 Apr; 168():293-300. PubMed ID: 30826506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and characterization of copper-based anticancer compound;
    Al-Asbahy WM; Shamsi M
    J Biomol Struct Dyn; 2021 Mar; 39(4):1431-1446. PubMed ID: 32090687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and cytotoxic evaluation of N2-benzylated quaternary beta-carboline amino acid ester conjugates.
    Ma C; Cao R; Shi B; Li S; Chen Z; Yi W; Peng W; Ren Z; Song H
    Eur J Med Chem; 2010 Apr; 45(4):1515-23. PubMed ID: 20122764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design of beta-carboline derivatives as DNA-targeting antitumor agents.
    Guan H; Chen H; Peng W; Ma Y; Cao R; Liu X; Xu A
    Eur J Med Chem; 2006 Oct; 41(10):1167-79. PubMed ID: 16790297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design and synthesis of C3-pyrazole/chalcone-linked beta-carboline hybrids: antitopoisomerase I, DNA-interactive, and apoptosis-inducing anticancer agents.
    Kamal A; Srinivasulu V; Nayak VL; Sathish M; Shankaraiah N; Bagul C; Reddy NV; Rangaraj N; Nagesh N
    ChemMedChem; 2014 Sep; 9(9):2084-98. PubMed ID: 24470122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spectroscopic investigation and in vitro cytotoxic activity toward HepG2 cells of a copper compound complexed with human serum albumin.
    Li M; Huang S; Cai Q; Xie Y
    Luminescence; 2017 Aug; 32(5):888-898. PubMed ID: 28371207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and cytotoxicity evaluation of (tetrahydro-beta-carboline)-1,3,5-triazine hybrids as anticancer agents.
    Kumar R; Gupta L; Pal P; Khan S; Singh N; Katiyar SB; Meena S; Sarkar J; Sinha S; Kanaujiya JK; Lochab S; Trivedi AK; Chauhan PM
    Eur J Med Chem; 2010 Jun; 45(6):2265-76. PubMed ID: 20207053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
    Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular hybrid design, synthesis, in vitro and in vivo anticancer evaluation, and mechanism of action of N-acylhydrazone linked, heterobivalent β-carbolines.
    Guo L; Chen X; Chen W; Ma Q; Fan W; Zhang J; Dai B
    Bioorg Chem; 2020 Mar; 96():103612. PubMed ID: 32007724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis,
    Chaudhary M; Kumar N; Baldi A; Chandra R; Arockia Babu M; Madan J
    J Biomol Struct Dyn; 2020 Jan; 38(1):200-218. PubMed ID: 30784365
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pictet-Spengler reactions for the synthesis of pharmaceutically relevant heterocycles.
    Pulka K
    Curr Opin Drug Discov Devel; 2010; 13(6):669-84. PubMed ID: 21061230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Traceless synthesis of hydantoin fused tetrahydro-beta-carboline on ionic liquid support in green media.
    Maiti B; Chanda K; Sun CM
    Org Lett; 2009 Nov; 11(21):4826-9. PubMed ID: 19807116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and Structure-Activity Relationships of Tetrahydro-β-carboline Derivatives as Anticancer and Cancer-chemopreventive Agents.
    Zhang M; Park EJ; Kondratyuk TP; Pezzuto JM; Sun D
    Anticancer Res; 2018 Aug; 38(8):4425-4433. PubMed ID: 30061206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of Structural Requirements of N-Substituted Tetrahydro-β-Carboline Imidazolium Salt Derivatives Using in Silico Approaches for Designing MEK-1 Inhibitors.
    Liang J; Wang M; Li X; He X; Cao C; Meng F
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28629184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The preparation and evaluation of 1-substituted 1,2,3,4-tetrahydro- and 3,4-dihydro-beta-carboline derivatives as potential antitumor agents.
    Shen YC; Chen CY; Hsieh PW; Duh CY; Lin YM; Ko CL
    Chem Pharm Bull (Tokyo); 2005 Jan; 53(1):32-6. PubMed ID: 15635225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phytochemical meanings of tetrahydro-β-carboline moiety in strictosidine derivatives.
    Sudžuković N; Schinnerl J; Brecker L
    Bioorg Med Chem; 2016 Feb; 24(4):588-95. PubMed ID: 26749326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and biological evaluation of novel N
    Guo L; Ma Q; Chen W; Fan W; Zhang J; Dai B
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):375-387. PubMed ID: 30734606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Synthesis and antitumor activity of novel tetrahydro-beta-carboline derivatives as KSP inhibitors].
    Ruan XQ; Chen M; Wu WT; You QD
    Yao Xue Xue Bao; 2013 Jul; 48(7):1119-23. PubMed ID: 24133978
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis, cytotoxic activities and DNA binding properties of β-carboline derivatives.
    Chen Z; Cao R; Yu L; Shi B; Sun J; Guo L; Ma Q; Yi W; Song X; Song H
    Eur J Med Chem; 2010 Nov; 45(11):4740-5. PubMed ID: 20716468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, Synthesis, and Biological Evaluation of Novel N-Acylhydrazone Bond Linked Heterobivalent β-Carbolines as Potential Anticancer Agents.
    Chen X; Guo L; Ma Q; Chen W; Fan W; Zhang J
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31416271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.